VMP 42080211000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Acarbose 100mg tablets
BNF code 0601023A0AAABAB
Virtual Therapeutic Moiety Acarbose
Date identifier became valid 21 Jul 2023
Previous product identifier 326038002
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Acarbose
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 100.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Acarbose 100mg tablets (A A H Pharmaceuticals Ltd)
Acarbose 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Acarbose 100mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Acarbose 100mg tablets (Medihealth (Northern) Ltd)
Acarbose 100mg tablets (Morningside Healthcare Ltd)
Acarbose 100mg tablets (Phoenix Healthcare Distribution Ltd)
Acarbose 100mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Acarbose 100mg tablets 100 tablet
Acarbose 100mg tablets 30 tablet
Acarbose 100mg tablets 90 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback